Phase 4
Completed N=10
12-Month Stability of Diurnal IOP Control on Cosopt
Source: ClinicalTrials.gov NCT00379834 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcomePrimary: Diurnal Intraocular Pressure Control — -4.4 millimeters of mercury
Summary
To determine the stability of diurnal intraocular pressure in eyes with glaucoma treated with Cosopt
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diurnal Intraocular Pressure Control |
-4.4 | — |
Eligibility Criteria
Inclusion Criteria
- bilateral open-angle glaucoma
Exclusion Criteria
- contraindications to Cosopt
- pathology affecting tonometry
Data sourced from ClinicalTrials.gov (NCT00379834). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.